Biomerica, Inc. announced that the American Medical Association's CPT editorial panel has granted a Proprietary Laboratory Analysis (PLA) code for its inFoods® IBS test, which personalizes the ...
Clinical study results show patients who eliminated foods as determined by the inFoods® IBS test experience significant improvement in IBS Symptoms Including Abdominal Pain Intensity (API) IRVINE, ...
Biomerica applies for a PLA code to enhance patient access to its inFoods IBS diagnostic test for personalized IBS management. Biomerica, Inc. has submitted an application to the American Medical ...
IRVINE, Calif. , May 07, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), a global biomedical company dedicated to the development of advanced diagnostic products, announced that the Company ...
Publication details large multicenter clinical trial demonstrating significant reductions in IBS symptoms through inFoods IBS guided dietary therapy IRVINE, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) -- ...
An elimination diet guided by a novel irritable bowel syndrome (IBS)–specific immunoglobulin G (IgG) assay reduced abdominal pain in a greater proportion of patients with IBS than a sham elimination ...
inFoods IBS showed improvement in API similar to, and in some cases better than, current IBS drugs in the market NEWPORT BEACH, Calif., May 18, 2023 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA), ...
The Chosun Ilbo on MSN
IBS symptoms unchanged in wheat/gluten test
Irritable bowel syndrome (IBS) is a condition characterized by frequent abdominal pain, alternating diarrhea and constipation ...
CMS is the single largest payer for healthcare in the United States, with Medicare responsible for approximately 21% of total healthcare expenditure. The $300 rate will apply to claims approved and ...
Approximately 76% of patients with irritable bowel syndrome (IBS) demonstrated hypersensitivity during a lactulose nutrient challenge test, with hypersensitivity associated with more severe ...
Commonwealth Diagnostics International will officially re-launch IBSchek, the first clinically validated blood test for diarrhea-predominant and mixed-type irritable bowel syndrome, at Digestive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback